When will shots like Ozempic be covered by health insurance?
GLP-1 drugs like Ozempic have long helped people eat less — now, they’re showing promise in helping people…
Cancer can kill you in a year. I found out the hard way what that’s like.
In the fall of 2022, when I was 42 and living with my wife and three young kids…
Scientists uncover how the immune system actively builds food tolerance
Food allergies are serious and, for some, potentially deadly. And yet, despite decades of research into allergies and…
Simplified nanoparticles “educate” the immune system to find and destroy disease-causing cells
Johns Hopkins Medicine scientists say they have developed a simplified version of biodegradable nanoparticles that can “educate” the…
Dual-positive hybrid cells linked to shorter survival in advanced breast cancer
An enigmatic type of circulating tumor cell called a dual-positive (DP) cell is associated with shorter survival time…
Foundation offers patients help with cost of cancer medications | Local News
Post-treatment cancer patients can qualify for up to $2,500 in medication assistance through a new program launched by…
Geographic location strongly influences stage of breast cancer diagnosis
Where a woman lives significantly affects whether her breast cancer is diagnosed at an early or late stage,…
Technology Is Reshaping Sleep Apnea Treatment
Inspire therapy—a hypoglossal nerve stimulation implant—has been FDA-approved for more than 11 years, with over 100,000 patients treated…
Boron-assisted reactions overcome solubility barriers in protein synthesis
Chemists from ETH Zurich have found a way to produce poorly soluble proteins by caging a uniquely reactive…
Global study reveals how inequality limits access to exercise and why it matters for health
A global analysis shows that who gets the chance to exercise is shaped by wealth and gender, while…
Using a smartwatch to detect changes in brain health
Can smartphones or smartwatches help detect early signs of neurological or mental illness? Researchers at the University of…
FOXJ1 gene may drive resistance to taxane chemotherapy in advanced prostate cancer
A gene called FOXJ1 may drive resistance to taxane chemotherapy during treatment for advanced prostate cancer, according to…